http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6ce874d45143ef1d82314d09c19bd94
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Nimer |
| name | Stephen D Nimer Stephen D. Nimer |
| given-name | Stephen D. Stephen D |
| organization-name | From the Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. Molecular Pharmacology and Chemistry Program and Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL;; Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL;; Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL From the Departments of Neurology and Medicine and the Office of Clinical Research, Memorial Sloan-Kettering Cancer Center, New York, NY; Princess Margaret Hospital, University of Toronto, Toronto; Tom Baker Cancer Center, University of Calgary, Calgary, Canada; and the Department of Neurology, Evanston Hospital, Northwestern University, Chicago, IL. Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY;; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL From the Laboratory of Molecular Aspects of Hematopoiesis and the Laboratory of Developmental Hematopoiesis, Sloan-Kettering Institute, New York, NY; and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Laboratory of Molecular Aspects of Hematopoiesis; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 Lymphoma Disease Management Team, Memorial Sloan-Kettering Cancer Center, New York, NY 1 From the Lymphoma Service and the Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY; Bone Marrow Transplant Program, Loyola University School of Medicine, Maywood, IL; Hematology/Oncology Division, Indiana University Medical Center, Indianapolis, IN; Stem Cell Transplant Program, University of California-San Diego Medical Center, San Diego; the Departments of Medicine and Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA; and Amgen Inc, Thousand Oaks, CA. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY;; University of Miami Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL Departments of Experimental Oncology and Biochemistry, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN 38105; Departments of Pediatrics and Biochemistry, University of Tennessee College of Medicine, 3 North Dunlap, Memphis, TN 38163; Department of Molecular Biology, Jichi Medical School, 3311–1 Yakushiji, Minamikawachi-machi, Tochigi 329–04, Japan; and Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York. Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY;; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL Laboratory of Molecular Aspects of Hematopoiesis, Sloan-Kettering Institute, New York, New York, USA 7Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida. Laboratory of Molecular Aspects of Hematopoiesis, Sloan‐Kettering Institute for Cancer Research, New York, New York, USA; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan‐Kettering Cancer Center, New York, New York, USA Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229; Sloan–Kettering Institute and Division of Hematologic Oncology, Memorial Sloan–Kettering Cancer Center, New York, NY 10021; and Department of Hematology, Erasmus University Medical Center, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands From the Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University; the Hematology Service, Memorial Sloan Kettering Cancer Center; and St Vincent's Cancer Center, New York, NY. Division of Hematologic Oncology and Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA. Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute and *Molecular Pharmacology and Chemistry Program; From the Dana-Farber Cancer Institute, Boston, MA; the Memorial Sloan-Kettering Cancer Center, New York, NY; the University of California–Los Angeles (UCLA) Medical Center; The Ohio State University Comprehensive Cancer Center, Columbus; Millennium Pharmaceuticals, Cambridge, MA; the University of Auckland, New Zealand; the Oregon Health and Science University Cancer Institute, Portland; and the Portland Veterans Administration (VA) Medical Center, OR. Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 From the University of Magdeburg, Magdeburg; Technischen Universität, Dresden University, Dresden, Germany; Dana-Farber Cancer Institute, Boston, MA; University of Texas, M. D. Anderson Cancer Center, Houston; Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX; Novartis Pharmaceuticals, Basel, Switzerland; Novartis Pharmaceuticals, East Hanover, NJ; Cornell University; Memorial Sloan-Kettering Cancer Center, New York, NY; and the University of California, Los... From the Laboratory of Molecular Aspects of Hematopoiesis and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York; and New York University Medical Center, Department of Microbiology, New York, NY. Correspondence: Bruce D. Cheson, National Cancer Institute, Executive Plaza North, Room 741, Bethesda, MD 20892; e-mail: 15Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida. From the Departments of Medicine, Radiation Oncology, Pathology, and Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY. Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136;; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136; Sylvester Comprehensive Cancer Center,; Department of Biochemistry and Molecular Biology,; Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, FL; and Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136 13; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136 14; Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136 15 4Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA Laboratory of Molecular Aspects of Hematopoiesis and Laboratory of Hemato-Oncology, Sloan–Kettering Institute, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA From the Lymphoma and Hematology Services, Division of Hematologic Oncology, Department of Medicine; Department of Biostatistics; and the Department of Radiation Oncology, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, NY. Author's Affiliation: Molecular Pharmacology and Chemistry Program of the Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York Correspondence: Sara Alvarez, Department of Human Genetics, Spanish National Cancer Center, Melchor Fernandez Almagro, 3, E-28029 Madrid, Spain; e-mail: From the Hematology Service, Division of Hematologic Oncology, Department of Medicine, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY. Sylvester Comprehensive Cancer Center, Miami, FL, 33136, USA. snimer@med.miami.edu. Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. snimer@med.miami.edu. From the Memorial Sloan-Kettering Cancer Center, New York, NY. Department of Biochemistry and Molecular Biology, University of Miami Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1550 NW 10th Avenue, FOX 200, Miami, FL 33136, USA From the Laboratory of Molecular Hematopoiesis, Sloan-Kettering Institute; the Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center; and the Laboratory of Developmental Hematopoiesis, Cell Biology Program, Sloan-Kettering Institute, New York, NY. Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute , New York, New York 3Department of Medicine, Hematology Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York Molecular Pharmacology and Chemistry Program of the Sloan-Kettering Institute; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York Sylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, and Department of Medicine, University of Miami Miller School of Medicine, Miami, FL. Department of Medicine, University of Miami Miller School of Medicine, Miami, FL Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 5Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 8Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL Authors' Affiliations: Departments of 1Medicine and 2Pathology, 3Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, 4Laboratory of New Drug Development, Memorial Sloan-Kettering Cancer Center, New York; and 5Department of Medicine, Tufts Medical Center, Boston, Massachusetts; Authors' Affiliations: Departments of 1Medicine and 2Pathology, 3Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, 4Laboratory of New Drug Development, Memorial Sloan-Kettering Cancer Center, New York; and 5Department of Medicine, Tufts Medical Center, Boston, Massachusetts From the Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY; and From the Lymphoma and Hematology Disease Management Teams, Departments of Medicine, Radiation Oncology, Pathology, Biostatistics, and Pediatrics, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY. Sloan-Kettering Institute;; Division of Hematologic Oncology, Department of Medicine;; Department of Clinical Laboratories; Division of Hematology-Oncology, UCLA School of Medicine and Jonsson Comprehensive Cancer Centter, Los Angeles, California 90024 From the Lymphoma and Hematology Services, Department of Medicine, and Departments of Radiotherapy, Pathology, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY. 2Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York; and 1Medicine, Departments of; 4Sloan-Kettering Institute, New York, New York; and From the Dana-Farber Cancer Institute, Boston, MA; MD Anderson Cancer Center, Houston, TX; Memorial Sloan-Kettering Cancer Center, New York, NY; and Novartis, Basel, Switzerland. From the Laboratory of Molecular Aspects of Hematopoiesis, Sloan-Kettering Institute, Genomics Core Laboratory and Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY. Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Sylvester Comprehensive Cancer Center, Miami, Florida, United States Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL;; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL;; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL Molecular Pharmacology and Chemistry Program and Cancer Biology and Genetics Program, Sloan-Kettering Institute, and the Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami FL USA From the Leukemia, Hematology, and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, and the Weill Medical College of Cornell University, New York, NY, and the Lady Davis Institute of the Jewish General Hospital, McGill University, Montreal, QC, Canada. Correspondence: Stephen D. Nimer, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021; e-mail: |
Incoming Links
Total number of triples: 276.